•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

S09523 Summary:

BILL NOS09523
 
SAME ASNo Same As
 
SPONSORCLEARE
 
COSPNSR
 
MLTSPNSR
 
Amd §§3216, 3221 & 4303, Ins L; amd §365-a, Soc Serv L
 
Provides for coverage for treatments to slow the progression of Alzheimer's disease and related dementias.
Go to top

S09523 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          9523
 
                    IN SENATE
 
                                     March 19, 2026
                                       ___________
 
        Introduced  by  Sen.  CLEARE -- read twice and ordered printed, and when
          printed to be committed to the Committee on Insurance
 
        AN ACT to amend the insurance  law  and  the  social  services  law,  in
          relation  to  coverage  for  treatments  to  slow  the  progression of
          Alzheimer's disease and related dementias
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Subsection  (i)  of  section 3216 of the insurance law is
     2  amended by adding a new paragraph 11-d to read as follows:
     3    (11-d) Every policy which provides medical, major medical, or  similar
     4  comprehensive-type  coverage  shall  provide  coverage for all medically
     5  necessary diagnostic testing and United States food and drug administra-
     6  tion-approved treatments or medications prescribed to slow the  progres-
     7  sion  of  Alzheimer's disease and other dementia, in accordance with the
     8  United States food and drug administration label,  as  determined  by  a
     9  physician licensed to practice medicine in all its branches. Coverage of
    10  United  States food and drug administration-approved treatments or medi-
    11  cations prescribed to slow the progression  of  Alzheimer's  disease  or
    12  another related dementia pursuant to this paragraph shall not be subject
    13  to step therapy.
    14    § 2. Subsection (l) of section 3221 of the insurance law is amended by
    15  adding a new paragraph 11-d to read as follows:
    16    (11-d) Every insurer delivering a group or blanket policy or issuing a
    17  group  or blanket policy for delivery in this state that provides cover-
    18  age for medical, major medical, or similar  comprehensive-type  coverage
    19  shall  provide  coverage  for all medically necessary diagnostic testing
    20  and United States food and drug  administration-approved  treatments  or
    21  medications  prescribed  to  slow the progression of Alzheimer's disease
    22  and other dementia, in accordance with the United States food  and  drug
    23  administration  label, as determined by a physician licensed to practice
    24  medicine in all its branches. Coverage of United States  food  and  drug
    25  administration-approved treatments or medications prescribed to slow the
    26  progression  of Alzheimer's disease or another related dementia pursuant
    27  to this paragraph shall not be subject to step therapy.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD15298-01-6

        S. 9523                             2
 
     1    § 3. Section 4303 of the insurance law is  amended  by  adding  a  new
     2  subsection (p-2) to read as follows:
     3    (p-2)  A  medical  expense  indemnity  corporation, a hospital service
     4  corporation or a health service corporation that provides  coverage  for
     5  medical,  major  medical,  or  similar comprehensive-type coverage shall
     6  provide coverage for all  medically  necessary  diagnostic  testing  and
     7  United  States food and drug administration-approved treatments or medi-
     8  cations prescribed to slow the progression of  Alzheimer's  disease  and
     9  other  dementia,  in  accordance  with  the  United States food and drug
    10  administration label, as determined by a physician licensed to  practice
    11  medicine  in  all  its branches. Coverage of United States food and drug
    12  administration-approved treatments or medications prescribed to slow the
    13  progression of Alzheimer's disease or another related dementia  pursuant
    14  to this subsection shall not be subject to step therapy.
    15    §  4.  Subdivision  2  of  section 365-a of the social services law is
    16  amended by adding a new paragraph (mm-1) to read as follows:
    17    (mm-1) all medically necessary diagnostic testing  and  United  States
    18  food   and   drug   administration-approved  treatments  or  medications
    19  prescribed to slow the progression  of  Alzheimer's  disease  and  other
    20  dementia,  in  accordance  with the United States food and drug adminis-
    21  tration label, as determined by a physician licensed to  practice  medi-
    22  cine in all its branches. Coverage of United States food and drug admin-
    23  istration-approved  treatments  or  medications  prescribed  to slow the
    24  progression of Alzheimer's disease or another related dementia  pursuant
    25  to this paragraph shall not be subject to step therapy.
    26    §  5. This act shall take effect on the first of January next succeed-
    27  ing the date on which it shall have become a law and shall apply to  all
    28  policies  and contracts issued, renewed, modified, altered or amended on
    29  or after such date.
Go to top